1133-156 Results of four multicenter, phase III, magnetic resonance angiography (MRA) trials with MS-325, a blood pool contrast agent, for the detection of vascular disease in the aortoiliac, renal, and pedal regions

✍ Scribed by Emile R Mohler III

• Book ID: 119549105
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 276 KB
• Volume: 43
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(04)91490-8